The next conference has just been announced for Thursday 24th October 2013, 13.30 to 17.00. This year it will take place at the Academy of Medical Sciences, 41 Portland Place, London W1B 1QH. There will be a panel of highly acclaimed academic and industry speakers.
Further details to follow soon.
Dear Members,
I have recently returned from a very successful and interesting International meeting in France held between the French (Club Phase 1), German (AGAH), Belgian (BAPU) and UK (AHPPI),human pharmacological societies. The meeting was entitled EARLY CLINICAL UTILITY ASSESSMENT OF NEW MEDICINES IN DEVELOPMENT and gave technical, ethical and regulatory overviews with workshops on pain, adaptive design, PK/PD modelling, cardiac safety and Bayesian statistics. There were eminent speakers and also speakers from most of the EU Regulatory bodies who clearly see us as a force to be reckoned with.
This meeting takes place every two years and it will be our turn to host it in 2017. I’m a little disappointed that there were not more attendees from UK but we were well represented amongst the speakers and session Chairs and involved in some interesting workshops. I am sure you would have enjoyed it as much as I did and I hope you will be able to join me in 2015 for the next meeting which will be held in Belgium.
Help us to increase our membership and tell you friends about the meeting and about AHPPI; the presentations are now available here.
Best wishes to you all.
Peter Dewland
AHPPI Chair
Dear Members,
I just wanted to update you on what we are up to and what is planned for 2013.
We had a very successful annual meeting last year and your committee is about to embark upon planning this year’s meeting; we would love to hear from you as to potential subjects/topics for this meeting. Your committee strives to make it interesting every year but values your input. Any burning topics then please let me or a committee member know your ideas.
We always value combining with our EU colleagues in their annual meetings and this year is time for the 2-yearly combined European meeting which will be held near Nice in April – details of which you will be able to find on our website or that of AGAH, Club Phase 1 or BAPU. This promises to be a very interesting meeting and we hope some of you will be able to support it by attending – I hope to see you there.
An important part of 2012 was to input into MHRA’s ideas on changes they are considering making to the Phase 1 Unit Accreditation scheme. We have to have our final answers by the last week of January so that we can submit them to MHRA. If you wish to have any input or make any comment then please let me or one of your Committee know by 20th January at latest.
We all look forward to a new and exciting year which, I am sure, will be very busy for us all. Please remember that this is your Association and it can only move forward with your help and input, which you can always share with us via email at info@ahppi.org.uk or on our website.
A Happy New Year to you all.
Peter Dewland
Committee Chair
The International Society for CNS Clinical Trials and Methodology (ISCTM) is looking for new investigators as potential candidates for their new award program. Interested parties can find further information by clicking below:
Following a successful meeting concerning improving the MHRA Phase 1 Accreditation Scheme on the 26th October,please click here for a summary of discussions and actions.
We would appreciate your comments by the 20th January 2013 to info@ahppi.org.uk.
The AHPPI has been invited by the MHRA to participate in a stakeholder group to discuss an update to the current Phase I Accreditation Scheme on Friday 26th October. The AHPPI will be represented by Peter Dewland and Graham Ridout.
Please review the documentation and email your comments to info@ahppi.org.uk by 19th October.
Please see link to letter by Richmond Pharmacology in response to the earlier TOPS article by Boyce et al.
The GCP inspectorate organises a GCP consultative committee with relevant interested parties, and answering any queries. For example, relating to GCP issues, GCP inspections and also parliamentary questions. The GCP Inspectorate holds symposia every year, in which updates from the inspection programme and new issues that may impact on the conduct of research (e.g. new legal requirements) are reviewed.
The AHPPI are collecting comments and queries from members to be raised at the next MHRA GCP Consultative Committee meeting. Please ensure that you provide your comments to info@ahppi.org.uk by 20 July 2012 so that we can compile an AHPPI document by the deadline of 10 August 2012.
Please see recent publication on TOPS Boyce et al. TOPS an internet-based system to prevent healthy subjects from over-volunteering for clinical trials. EJCP 2012 copy
Following recent nominations there is a new committee. Malcolm stepped down as chair but John Kelly, Corinthia Joseph, Ulrike Lorch, Mike Hammond and Peter Dewland were returned for another term of office. A new member is welcomed in the form of Keith Wesnes, a veteran of the CRO industry! Welcome Keith.